BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

...using its ubiquitin mediated small molecule induced target elimination (uSMITE) platform to identify protein degraders. EdiGENE Corp....
...ectonucleotide pyrophosphatase/phosphodiesterase 1; PRLR - Prolactin receptor BioCentury Staff INZ-701 Cullgen Inc. Inozyme Pharma Inc. Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Prolactin receptor (PRLR) EdiGENE Corp. Hope...
Items per page:
1 - 1 of 1
BioCentury | Apr 10, 2019
Financial News

Venture roundup: Inozyme, Cullgen, EdiGENE, Hope Medicine

...using its ubiquitin mediated small molecule induced target elimination (uSMITE) platform to identify protein degraders. EdiGENE Corp....
...ectonucleotide pyrophosphatase/phosphodiesterase 1; PRLR - Prolactin receptor BioCentury Staff INZ-701 Cullgen Inc. Inozyme Pharma Inc. Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) Prolactin receptor (PRLR) EdiGENE Corp. Hope...
Items per page:
1 - 1 of 1